A Study of Chemotherapy with Experimental Crizotinib vs. Placebo For Non-Small Cell Lung Cancer After Surgery
Can targeted chemotherapy with Crizotinib, stop the growth of tumor cells by blocking the a protein from working?
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Davis UCSD UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Lyudmila A. Bazhenova (ucsd)Tianhong Li (ucdavis)Karen G. Chee (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators. - Tianhong Li (ucdavis)
Associate Professor, Hematology and Oncology. Authored (or co-authored) 65 research publications - Karen G. Chee (ucsf)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- ECOG-ACRIN Cancer Research Group
- ID
- NCT02201992
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 168 study participants
- Last Updated